Please use this identifier to cite or link to this item:

Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrekke, Kurt R.por
dc.contributor.authorDalen, Dag Mortenpor
dc.contributor.authorStraume, Odd Runepor
dc.description.abstractWe study the incentives of drug producers to develop predictive biomarkers, taking into account strategic interaction between drug producers and health plans.For this purpose we develop a two-dimensional spatial frame work that allows us to capture the informational role of biomarkers and their effects on price competition and treatment choices. Although biomarkers increase the information available to prescribers, we identify an anticompetitive effect on the prices set by producers of therapeutically substitutable drugs. We also find that better information about each patient's most therapeutically appropriate drug does not necessarily lead to more efficient treatment outcomes.por
dc.publisherUniversidade do Minho. Núcleo de Investigação em Políticas Económicas (NIPE)por
dc.subjectPharmaceutical marketspor
dc.subjectPrecision medicinepor
dc.subjectTherapeutic competitionpor
dc.subjectPredictive biomarkerspor
dc.titleCompeting with precision: incentives for developing predictive biomarker testspor
oaire.citationIssueNIPE WP 03/2022por
oaire.citationConferencePlaceBraga, Portugalpor
Appears in Collections:NIPE - Documentos de Trabalho

Files in This Item:
File Description SizeFormat 
WP_03_2022.pdfCompeting with precision: incentives for developing predictive biomarker tests394,83 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID